Compare Recursion Pharmaceuticals Inc (RXRX) vs Xcel Energy Inc (XEL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Recursion Pharmaceuticals Inc vs Xcel Energy Inc — how do they compare? Recursion Pharmaceuticals Inc trades at $3.36 (market cap $1.81B), while Xcel Energy Inc trades at $77.66 (market cap $48.51B). The key difference: Xcel Energy Inc is far larger — about 26.8× Recursion Pharmaceuticals Inc's market cap, and Xcel Energy Inc pays a 3.05% dividend while Recursion Pharmaceuticals Inc pays none. Which is the better fit depends on your goals.
| RXRX | XEL | |
|---|---|---|
Market Cap | $1.81B | $48.51B |
Sector | Health | Utilities |
52-Week High | $6.79 | $83.91 |
52-Week Low | $2.84 | $71.75 |
Enterprise Value | $1.33B | $86.82B |
Dividend Yield | — | 3.05% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Recursion Pharmaceuticals Inc
Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company leveraging artificial intelligence (AI) and machine learning to industrialize drug discovery. The company's unique approach combines one of the world's largest biological and chemical datasets with automated wet-lab and computational systems to map human biology and identify potential therapeutic candidates across a range of diseases, including oncology and rare diseases. Recursion aims to accelerate the traditionally slow and expensive process of drug development.
Read more on RXRX →About Xcel Energy Inc
Xcel Energy manages utilities serving 3.7 million electric customers and 2.1 million natural gas customers in eight states. Its utilities are Northern States Power, which serves customers in Minnesota, North Dakota, South Dakota, Wisconsin, and Michigan
Read more on XEL →
